ALL and AML comprise different genetic abnormalities [32,33], and analysis of growth factor receptor expression and global gene expression has pointed out that the expression of receptor tyrosine kinases and signaling modulators are different [34,35]. The gene discussed is NTRK1; the disease is acute myeloid leukemia.